INBRAIN Neuroelectronics’ Post

pharmaphorum speaks with our CEO Carolina Aguilar about our work at INBRAIN Neuroelectronics. 🧠🧠 Inbrain Neuroelectronics is a European company that is also working with BCIs, but is taking a different approach by using graphene-based neural technologies and by focusing its work on existing medicinal approaches. The company recently announced that it had secured Series B funding that totalled $50 million, which Inbrain will use to develop its BCI technology and support on-going clinical trials. The potential for #graphene to revolutionise #nanotechnology, particularly in the medical sphere, has been discussed for years. In the case of Inbrain, the material, which is the thinnest material known to science and stronger than steel, is used in the implantable neural processor. Read the full article by Ben Hargreaves: 👇👇 https://lnkd.in/eeQihZwm #BCI #neurotechnology Graphene Flagship

Brain-computer interfaces could redefine precision medicine

Brain-computer interfaces could redefine precision medicine

pharmaphorum.com

To view or add a comment, sign in

Explore topics